Financial News
Latest News about VRTX
Recent news which mentions VRTX
This Beaten-Down ETF Is Still a Screaming Bear-Market Buy
October 21, 2022
From Motley Fool
These 27 stocks can give you a more diversified portfolio than the S&P 500 — and that’s a key advantage right now
October 19, 2022
From MarketWatch
2 Unstoppable Stocks That Are Beating the Bear Market
October 19, 2022
From Motley Fool
2 Top Healthcare Stocks to Buy for the Long Haul
October 18, 2022
From Motley Fool
My Best Stocks to Buy Now and Hold Forever
October 14, 2022
From Motley Fool
3 Red-Hot Stocks That Could Continue to Beat the Market
October 13, 2022
From Motley Fool
The Best Stocks to Invest $5,000 in Right Now
October 13, 2022
From Motley Fool
2 Breakout Growth Stocks to Buy for the Long Haul
October 12, 2022
From Motley Fool
Is Seagen Stock a Buy Now?
October 12, 2022
From Motley Fool
The Best Stocks to Invest $50,000 in Right Now
October 12, 2022
From Motley Fool
From Motley Fool
Vertex Moves Its Alpha-1 Antitrypsin Deficiency Program Forward
October 11, 2022
Tickers
VRTX
From Benzinga
3 Top Biotech Stocks Defying the Bear Market
October 11, 2022
From Motley Fool
These 7 Biotech Stocks Are Set to Boom in 2023
October 10, 2022
Tags
NYSE:ABBV,NASDAQ:REGN,NASDAQ:VRTX,NASDAQ:CRSP,NASDAQ:BIIB,NYSE:LLY,NASDAQ:AXSM,NASDAQ:EXEL
Stocks to Buy
REGN
From InvestorPlace
2 Cathie Wood Stocks That Are Beating the Market This Year
October 07, 2022
From Motley Fool
4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire
October 07, 2022
From Motley Fool
3 Stocks Savvy Investors Are Buying Hand Over Fist
October 06, 2022
From Motley Fool
Why Vertex Pharmaceuticals' Shares Rose 2.8% in September
October 05, 2022
Tickers
VRTX
From Motley Fool
Where to Invest $500 Right Now
October 05, 2022
From Motley Fool
3 Healthcare Stocks That Could Make You Richer
October 05, 2022
From Motley Fool
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
October 04, 2022
From Motley Fool
From Motley Fool
Bluebird Bio Offers World's Most Expensive Drugs, But Uncertainty Looms Over Its Financial Future
October 03, 2022
From Benzinga
3 Growth Stocks Poised to Skyrocket
October 01, 2022
From Motley Fool
Got $1,000? 2 Safe Stocks to Buy This Month
September 30, 2022
From Motley Fool
3 Stocks to Buy if You're Afraid to Buy Stocks
September 29, 2022
From Motley Fool
MaxCyte Inks Platform License With Vertex For Gene-Editing Program For Rare Blood Disorders
September 28, 2022
From Benzinga
3 Biotech Stocks to Buy and Hold for the Next 10 Years
September 28, 2022
From Motley Fool
The 2 Best Stocks to Invest $5,000 in Right Now
September 28, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.